Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04095234 · ClinicalTrials.gov registry record · Phase 2

Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)

A Phase 2 study of Cancer Pain, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
Phase 2
Development phase
300
Enrollment target
8
Study locations

NCT04095234 is a Phase 2 study of Cancer Pain that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 300 participants, above the 142-participant average among 15 other Cancer Pain trials with a reported enrollment target (111% higher). The trial reports 8 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04095234, a Phase 2 study of Cancer Pain, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
300 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to compare the long-term effectiveness of acupuncture versus massage in people living with advanced cancer. The study will test how the two approaches compare in helping people with pain and its related symptoms and improving quality of life.

Conditions Studied

Interventions

  • PROCEDURE Acupuncture
  • PROCEDURE Massage

Study Locations (8)

New York

  • Memorial Sloan Kettering Commack (All Protocol Activities) - Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (All Protocol Activities) - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) - Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities) - Montvale

Florida

  • Baptist Alliance MCI - Miami

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2019-09-17
Est. Completion 2026-09
Phase Phase 2

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT04095234

The ClinicalTrials.gov registry entry for NCT04095234 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 142-participant average among 15 other Cancer Pain trials with a reported enrollment target (111% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer Pain appearing as the primary indexed condition, and to 2 interventions - of which Acupuncture is the first listed.

NCT04095234 reports 8 study locations spanning 3 distinct geographic areas - top geographies include New York, New Jersey, Florida.

Frequently Asked Questions

What is clinical trial NCT04095234 about?

NCT04095234 is a clinical study titled "Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)". The purpose of this study is to compare the long-term effectiveness of acupuncture versus massage in people living with advanced cancer. The study will test how the two approaches compare in helping people with pain and its related symptoms and improving quality of life.

What is the current status of trial NCT04095234?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2019-09-17. Estimated completion is 2026-09.

What conditions does trial NCT04095234 study?

This clinical trial studies the following conditions: Cancer Pain.

What interventions are being tested in trial NCT04095234?

The interventions under investigation include: Acupuncture (PROCEDURE), Massage (PROCEDURE).

Who is sponsoring clinical trial NCT04095234?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04095234 being conducted?

This trial has 8 study locations across Florida, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.